{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/302847255"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "The reasons for this include issues such as 1) biochemical challenges in developing new compounds, 2) strict FDA regulations on efficacy and safety for any new product brought to market, 3) the expense involved by a pharmaceutical company in research and development necessary for product licensure, 4) the low profit margin in antibiotics which are used for short durations as compared to drugs pres" ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "issuu.com" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/17367149"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/302847255"] } } }
